ArticleJHLT open2025
Beyond the consult: Outcomes following pediatric VAD referral.
Article in JHLT open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Little is known about patients who are referred for ventricular assist device (VAD) therapy but not implanted. The purpose of this study is to describe their outcomes at 1-year post initial consultation. Methods: Retrospective analysis for patients referred to our VAD services between 01/2019 and 12/2023. Outcomes were reported at 30 days and 1-year post-consult. Patients who died, were too unwell for VAD or required extracorporeal membrane oxygenation (ECMO) within 30 days of consultation were considered acute referrals. Multivariate logistic regression analysis was used to determine risk factors for being an acute referral. Results: There were 128 patients included, with median age at referral 2.7 years (IQR 0.3, 0.9), 50.8% being male, and 52.3% of patients having congenital heart disease (CHD). The primary indication for VAD consult was due to the patient undergoing a transplant evaluation. At 30 days 31% ( Conclusion: Of patients referred to the VAD service, one-third were considered acute referrals. Patients who were acute referrals had increased 1-year mortality than those who were elective referrals. Factors associated with being an acute referral included diagnosis of biventricular CHD or other and no co-morbidities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.